Robert Leman to Defibrillators, Implantable
This is a "connection" page, showing publications Robert Leman has written about Defibrillators, Implantable.
Connection Strength
1.106
-
Clinical trials update: sudden cardiac death prevention by implantable device therapy. Crit Care Nurs Clin North Am. 2005 Mar; 17(1):33-8, x.
Score: 0.189
-
The Effect of Chronic Kidney Disease on Mortality with Cardiac Resynchronization Therapy. Pacing Clin Electrophysiol. 2016 Aug; 39(8):863-9.
Score: 0.103
-
The impact of device recall on patients and family members of patients with automatic implantable cardioverter defibrillators. Heart Lung. 1994 Jul-Aug; 23(4):317-22.
Score: 0.090
-
Cerebral monitoring during implantation of automatic internal cardiac defibrillators. South Med J. 1993 May; 86(5):533-6.
Score: 0.083
-
Safety of continuous anticoagulation with dabigatran during implantation of cardiac rhythm devices. Am J Cardiol. 2013 Apr 15; 111(8):1165-8.
Score: 0.082
-
Defibrillation thresholds in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2011 May; 22(5):569-72.
Score: 0.070
-
Randomized comparison of defibrillation thresholds from the right ventricular apex and outflow tract. Heart Rhythm. 2010 Nov; 7(11):1561-6.
Score: 0.068
-
Disparities in preferences for receiving support and education among patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2009 Mar; 32(3):383-90.
Score: 0.063
-
Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008 Nov 18; 52(21):1718-23.
Score: 0.061
-
Optimization of superior vena cava coil position and usage for transvenous defibrillation. Heart Rhythm. 2008 Mar; 5(3):394-9.
Score: 0.057
-
Time to resumption of driving after implantation of an automatic defibrillator (from the Dual chamber and VVI Implantable Defibrillator [DAVID] trial). Am J Cardiol. 2005 Mar 01; 95(5):665-6.
Score: 0.047
-
Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial. Card Electrophysiol Rev. 2003 Dec; 7(4):341-4.
Score: 0.043
-
Clinical investigation of a new dual-chamber implantable cardioverter defibrillator with improved rhythm discrimination capabilities. J Cardiovasc Electrophysiol. 2003 Feb; 14(2):144-9.
Score: 0.041
-
Safety of a single successful conversion of ventricular fibrillation before the implantation of cardioverter defibrillators. Pacing Clin Electrophysiol. 2003 Jan; 26(1P2):483-6.
Score: 0.041
-
Driving with an internal defibrillator: legal, ethical, and quality-of-life issues. J Cardiovasc Nurs. 1997 Jan; 11(2):58-67.
Score: 0.027
-
Driving safety among patients with automatic implantable cardioverter defibrillators. JAMA. 1993 Oct 06; 270(13):1587-8.
Score: 0.021
-
Role of transesophageal echocardiography among patients with atrial fibrillation undergoing electrophysiology testing. Am J Cardiol. 2009 Nov 01; 104(9):1256-8.
Score: 0.016